Last $0.99 USD
Change Today -0.0021 / -0.21%
Volume 713.3K
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven B. Ketchum Ph.D.

Senior Vice President and President of Research & Development, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
49$613,138
As of Fiscal Year 2013

Background*

Dr. Steven B. Ketchum, PhD has been a Senior Vice President and President of Research & Development at Amarin Corporation Plc Since February 16, 2012. Dr. Ketchum served as Senior Vice President of Research and Development at Sunesis Pharmaceuticals Inc. from June 2008 to February 2012. Dr. Ketchum has more than fifteen years experience in late-stage product development and clinical regulatory strategy, having led the filings of multiple successful New Drug Applications ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

2012-Present
Director

Education*

PhD
University College London
BS
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

Salary$384,313
Total Annual Compensation$384,313

Stock Options*

Exercisable Options283,438
Unexercisable Options350,312
Total Number of Options633,750

Total Compensation*

Total Annual Cash Compensation$384,313
Total Short Term Compensation$384,313
Total Calculated Compensation$613,138
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $0.99 USD -0.0021

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
--
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.